stars 1 stars 2 stars 3

Stratifind is an oncology diagnostics company advancing RNA + DNA–based prognostic and predictive testing to improve cancer treatment decisions. Our platform goes beyond mutation detection to identify which patients are most likely to respond to specific therapies, empowering oncologists with actionable insights and enabling biopharma partners to accelerate translational research and drug development. We also work with diagnostics innovators who are uncertain about commercialization, reimbursement, or clinical adoption—helping them navigate complexity and find the right path forward. Anchored in tissue-based gene expression and enhanced with algorithmic interpretation, Stratifind is engaging a CLIA-certified lab, pursuing reimbursement pathways, and forging partnerships to scale precision oncology. Our mission is simple: bring clarity to cancer care, advance translational research, and guide emerging diagnostics companies toward meaningful impact.

Website https://stratifind.io
Employees 4 (0 on RocketReach)
Founded 2025
Industry Medical and Diagnostic Laboratories

Stratifind Questions

Stratifind is based in New York, New York.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users